Summary
This prediction ended on 05.05.23 with a price of €358.00. BiotechBee's BUY prediction for Argenx SE closed unchanged from the start price. BiotechBee has a follow-up prediction for Argenx SE where he still thinks Argenx SE is a Buy. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Argenx SE | - | - | - |
iShares Core DAX® | -1.941% | -4.109% | 11.238% |
iShares Nasdaq 100 | -3.642% | -10.625% | 21.511% |
iShares Nikkei 225® | -2.728% | -6.434% | 8.146% |
iShares S&P 500 | -3.440% | -5.152% | 20.197% |
According to BiotechBee what are the pros and cons of Argenx SE for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Argenx SE diskutieren
Buy mit Kursziel 500,0
In the thread Trading Argenx SE
Buy beendet